Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2011
11/29/2011CA2235224C Diagnostics and treatments of periodontal disease
11/29/2011CA2199896C Liquid septic tank treatment composition
11/24/2011WO2011146833A1 Method of producing isoprenoid compounds in yeast
11/24/2011WO2011146715A1 Compositions and methods for the delivery of therapeutic peptides
11/24/2011WO2011146046A1 System for seeding cells onto three dimensional scaffolds
11/24/2011WO2011145764A1 Microorganism for quantifying homocysteine, and use thereof
11/24/2011WO2011145688A1 Method for processing acidic solution that contains iodide ions and iron ions
11/24/2011WO2011145525A1 Alanine-rich seasoning composition
11/24/2011WO2011145518A1 Aldehyde removing composition
11/24/2011WO2011145516A1 Method for inhibition of methane production
11/24/2011WO2011145211A1 Ketoreductase mutant
11/24/2011WO2011144739A1 Hyperproliferative recombinant cell
11/24/2011WO2011144304A1 Universally applicable lysis buffer and processing methods for the lysis of bodily samples
11/24/2011WO2011143800A1 Bacillus coagulans strain used in producing l-lactic acid and use thereof
11/24/2011WO2011143749A2 Biomass production
11/24/2011WO2011143741A1 Extenders for mammalian sperm processing and preservation
11/24/2011WO2011143706A1 Methods relating to an attenuated mycoplasma
11/24/2011WO2011123811A3 Production of post-translationally hydroxylated recombinant proteins in bacteria
11/24/2011WO2011108916A3 A method for recovering an intracellular polyhydroxyalkanoate (pha)
11/24/2011WO2011107483A3 Enzyme aspartokinase iii having a reduced l-lysine feedback inhibition
11/24/2011WO2011090985A3 Generation of asporogenous solventogenic clostridia
11/24/2011WO2011089151A3 Method for producing methane gas
11/24/2011WO2011088425A3 Electro-autotrophic synthesis of higher alcohols
11/24/2011WO2011073769A3 Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition
11/24/2011WO2011060431A3 Multivalent live vector vaccine against clostridium difficile-associated disease
11/24/2011WO2011044326A3 Substrate-selective co-fermentation process
11/24/2011US20110289633 Mutated eif4e sequences from potato which are useful in imparting virus resistance
11/24/2011US20110289632 Methylketone synthase, production of methylketones in plants and bacteria
11/24/2011US20110289630 Method for the expression in plant of the glutamic acid decarboxylase (gad65) and related expression vectors
11/24/2011US20110289627 Modified cry3a toxins and nucleic acid sequences coding therefor
11/24/2011US20110289624 Gene-transfer vector comprising helper-component protease gene of papaya ringspot virus for broad-spectrum virus resistance in crops and use thereof
11/24/2011US20110289623 Compositions and methods for the modification of gene expression
11/24/2011US20110289622 Expression cassettes for transgenic expression of nucleic acids
11/24/2011US20110289611 Rna sequence-specific mediators of rna interference
11/24/2011US20110289609 Neurotransmitter Sensors and Methods of Using the Same
11/24/2011US20110289607 Method of inhibiting gene expression
11/24/2011US20110288272 Modified cry3a toxins and nucleic acid sequences coding therefor
11/24/2011US20110288008 Antibacterial and plasmid elimination agents
11/24/2011US20110287979 Methods for Identifying and Isolating Cells Expressing a Polypeptide
11/24/2011US20110287971 Multi-chain eukaryotic display vectors and uses thereof
11/24/2011US20110287950 Protein fragment complementation assays for the detection of biological or drug interactions
11/24/2011US20110287544 Photobioreactor Systems Positioned on Bodies of Water
11/24/2011US20110287541 Accordion bioreactor
11/24/2011US20110287526 Process for growing biomass by modulating inputs to reaction zone based on changes to exhaust supply
11/24/2011US20110287525 Diluting exhaust gas being supplied to bioreactor
11/24/2011US20110287524 Methods and systems for predictive design of structures based on organic models
11/24/2011US20110287523 Recovering make-up water during biomass production
11/24/2011US20110287522 Producing biomass using pressurized exhaust gas
11/24/2011US20110287521 Biosynthesis of commodity chemicals
11/24/2011US20110287520 Salmonella marker vaccine
11/24/2011US20110287515 Protein and dna sequence encoding a cold adapted xylanase
11/24/2011US20110287514 Cytotoxic ribonuclease variants
11/24/2011US20110287512 Compositions for linking zinc finger modules
11/24/2011US20110287511 Novel Trichoderma Genes
11/24/2011US20110287506 Genetically modified yeast species, and fermentation processes using genetically modified yeast
11/24/2011US20110287505 Genetically modified yeast species, and fermentation processes using genetically modified yeast
11/24/2011US20110287501 Increased ethanol production in recombinant bacteria
11/24/2011US20110287500 Cytosolic isobutanol pathway localization for the production of isobutanol
11/24/2011US20110287499 Nucleic Acid Molecules Conferring Enhanced Ethanol Tolerance And Microorganisms Having Enhanced Tolerance To Ethanol
11/24/2011US20110287494 Process for production of optically active amine derivative
11/24/2011US20110287488 Novel n-acetylglucosamine-2-epimerase and method for producing cmp-neuraminic acid using the same
11/24/2011US20110287484 Expression vector containing the major envelope protein p9 of cystovirus phi6 as a fusion partner, and process for producing a membrane protein using the same
11/24/2011US20110287483 Production of glycoproteins using manganese
11/24/2011US20110287481 Host, transformant and method for producing the transformant and method for producing o-glycosylated heterologous protein
11/24/2011US20110287480 Neurogenin
11/24/2011US20110287474 Cultures and protocols for diagnosis of toxigenic clostridium difficile
11/24/2011US20110287471 System and Method of Producing Volatile Organic Compounds from Fungi
11/24/2011US20110287467 Methods of producing recombinant heme-binding proteins and uses thereof
11/24/2011US20110287440 Composition and method for reconstituting IkB kinase in yeast and method of using same
11/24/2011US20110287439 Clastogenicity testing
11/24/2011US20110287405 Biomass production
11/24/2011US20110287143 Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract
11/24/2011US20110287139 ABFB-2 gene from penicillium funiculosum
11/24/2011US20110287135 Novel arabinohydrolases
11/24/2011US20110287055 Compositions comprising prfa* mutant listeria and mehtods of use thereof
11/24/2011US20110287052 Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
11/24/2011US20110287050 Recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi
11/24/2011US20110287046 Modified streptococcus pneumonia pneumolysin (ply) polypeptides
11/24/2011US20110287043 Melanoma antigens and their use in diagnostic and therapeutic methods
11/24/2011US20110287037 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
11/24/2011US20110287033 Use of ferritin to treat iron disorders
11/24/2011US20110287015 Mg53 compositions and methods of use
11/24/2011US20110287014 Antibodies directed against calcium channel subunit alpha2/delta and methods using same
11/24/2011US20110287011 DDR1-Binding Agents and Methods of Use Thereof
11/24/2011US20110287004 Mg53 compositions and methods of use
11/24/2011US20110286996 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof
11/24/2011US20110286984 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
11/24/2011US20110286982 Glucagon analogues
11/24/2011US20110286981 Glucagon analogues
11/24/2011US20110286916 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
11/24/2011US20110284161 Biological glue and method for obtaining a biological glue
11/24/2011CA2799988A1 Biomass production
11/24/2011CA2799795A1 System and method of producing volatile organic compounds from fungi
11/24/2011CA2799732A1 Methods relating to an attenuated mycoplasma
11/24/2011CA2799599A1 Universally applicable lysis buffer and processing methods for the lysis of bodily samples
11/24/2011CA2799584A1 Hyperproliferative recombinant cell
11/24/2011CA2799244A1 System for seeding cells onto three dimensional scaffolds
11/23/2011EP2388323A2 Humanized anti-9 integrin antibodies and the uses thereof
11/23/2011EP2388321A1 Novel expression vector
11/23/2011EP2388313A2 Direct-Fed Microbial